These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21525384)

  • 1. Analysis and modeling of the variable region of camelid single-domain antibodies.
    Sircar A; Sanni KA; Shi J; Gray JJ
    J Immunol; 2011 Jun; 186(11):6357-67. PubMed ID: 21525384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global analysis of VHHs framework regions with a structural alphabet.
    Noël F; Malpertuy A; de Brevern AG
    Biochimie; 2016 Dec; 131():11-19. PubMed ID: 27613403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops.
    Decanniere K; Desmyter A; Lauwereys M; Ghahroudi MA; Muyldermans S; Wyns L
    Structure; 1999 Apr; 7(4):361-70. PubMed ID: 10196124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features.
    Harmsen MM; Ruuls RC; Nijman IJ; Niewold TA; Frenken LG; de Geus B
    Mol Immunol; 2000 Aug; 37(10):579-90. PubMed ID: 11163394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregation-resistant VHs selected by in vitro evolution tend to have disulfide-bonded loops and acidic isoelectric points.
    Arbabi-Ghahroudi M; To R; Gaudette N; Hirama T; Ding W; MacKenzie R; Tanha J
    Protein Eng Des Sel; 2009 Feb; 22(2):59-66. PubMed ID: 19033278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies.
    Saerens D; Pellis M; Loris R; Pardon E; Dumoulin M; Matagne A; Wyns L; Muyldermans S; Conrath K
    J Mol Biol; 2005 Sep; 352(3):597-607. PubMed ID: 16095608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of heavy and light chain sequences of conventional camelid antibodies from Camelus dromedarius and Camelus bactrianus species.
    Griffin LM; Snowden JR; Lawson AD; Wernery U; Kinne J; Baker TS
    J Immunol Methods; 2014 Mar; 405():35-46. PubMed ID: 24444705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform.
    Klarenbeek A; El Mazouari K; Desmyter A; Blanchetot C; Hultberg A; de Jonge N; Roovers RC; Cambillau C; Spinelli S; Del-Favero J; Verrips T; de Haard HJ; Achour I
    MAbs; 2015; 7(4):693-706. PubMed ID: 26018625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel promiscuous class of camelid single-domain antibody contributes to the antigen-binding repertoire.
    Deschacht N; De Groeve K; Vincke C; Raes G; De Baetselier P; Muyldermans S
    J Immunol; 2010 May; 184(10):5696-704. PubMed ID: 20404276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop.
    Fanning SW; Horn JR
    Protein Sci; 2011 Jul; 20(7):1196-207. PubMed ID: 21557375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of CDR3 to V H H domain stability and the design of monobody scaffolds for naive antibody libraries.
    Bond CJ; Marsters JC; Sidhu SS
    J Mol Biol; 2003 Sep; 332(3):643-55. PubMed ID: 12963373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction.
    Oliva B; Bates PA; Querol E; Avilés FX; Sternberg MJ
    J Mol Biol; 1998 Jun; 279(5):1193-210. PubMed ID: 9642095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid Monte Carlo with multidimensional replica exchanges: conformational equilibria of the hypervariable regions of a llama VHH antibody domain.
    Fenwick MK; Escobedo FA
    Biopolymers; 2003 Feb; 68(2):160-77. PubMed ID: 12548621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Superhumanized" antibodies: reduction of immunogenic potential by complementarity-determining region grafting with human germline sequences: application to an anti-CD28.
    Tan P; Mitchell DA; Buss TN; Holmes MA; Anasetti C; Foote J
    J Immunol; 2002 Jul; 169(2):1119-25. PubMed ID: 12097421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of a non-camelized human M12-V(H) domain at 1.5A resolution.
    Gaur RK
    J Struct Biol; 2005 Oct; 152(1):84-9. PubMed ID: 16183303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of antigen binding and idiotypic expression by antibodies with polyglycine-replaced complementarity-determining regions.
    Sompuram SR; Den W; Sharon J
    J Immunol; 1996 Feb; 156(3):1071-81. PubMed ID: 8557981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced conformational diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue.
    Kim ST; Shirai H; Nakajima N; Higo J; Nakamura H
    Proteins; 1999 Dec; 37(4):683-96. PubMed ID: 10651282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline-Dependent Antibody Paratope States and Pairing Specific V
    Fernández-Quintero ML; Kroell KB; Bacher LM; Loeffler JR; Quoika PK; Georges G; Bujotzek A; Kettenberger H; Liedl KR
    Front Immunol; 2021; 12():675655. PubMed ID: 34447370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures.
    Zemlin M; Klinger M; Link J; Zemlin C; Bauer K; Engler JA; Schroeder HW; Kirkham PM
    J Mol Biol; 2003 Dec; 334(4):733-49. PubMed ID: 14636599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.